Clinical Pharmacogenomic Variants Among the Saudi Population and Their Impact on Drug Response: A Review of Saudi-Based Evidence. [PDF]
Alqurain A +14 more
europepmc +1 more source
Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Gene Polymorphisms Predict Arterial Stiffness and Serum MGP Levels in Chronic Kidney Disease Patients. [PDF]
Chen DH +5 more
europepmc +1 more source
The Genetic Polymorphisms of CYP2C9 and VKORC1 in the Saudi Population and Their Impact on Anticoagulant Management. [PDF]
Al Hamad M.
europepmc +1 more source
A new nuclear marker, the "VKORC1 gene exon 3 region", for the identification of Anatolian Rattus spp. [PDF]
Çetintürk D, Duman MT, Yiğit N.
europepmc +1 more source
Prevalence of risk phenotypes associated with <i>CYP2C9*2, *3,</i> and <i>VKORC1 c.-1639G>A</i> genetic polymorphisms in world populations: implications in clinical practice. [PDF]
Biswas M +6 more
europepmc +1 more source
The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting [PDF]
Beitelshees, AL +26 more
core +1 more source
Clinical Application of Pharmacogenomics in Stroke Management: Current Evidence and Future Directions. [PDF]
Lee KJ +18 more
europepmc +1 more source
Application of Loading Dose Warfarin in Postpartum Women with Pulmonary Embolism - a Prospective, Randomized, Double-Blind Trial. [PDF]
Huang W, Sun H, Zhou L, Chen Y, Huo Y.
europepmc +1 more source
SNP genotypes in CYP2C9 and VKORC1 genes do not affect prostate cancer or cancer mortality among warfarin users in Finnish prostate cancer patients. [PDF]
Murtola TJ +8 more
europepmc +1 more source
Risk mitigation measures for anticoagulant rodenticides as biocidal products [PDF]
Berney, P. +3 more
core +1 more source

